KDR and neoplasm: These ligands, especially VEGF-A, bind to receptors such as VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3, along with the coreceptor neuropilins, to induce normal and tumor-associated angiogenesis [60].